801
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Are there new emerging drugs for ankylosing spondylitis or spondyloarthritis?

, MD PhD
Pages 5-7 | Published online: 07 Dec 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniel Wendling. (2013) Looking for the best target for biologic treatment of spondyloarthritis. Expert Review of Clinical Immunology 9:11, pages 1005-1007.
Read now

Articles from other publishers (4)

Alireza Rezaiemanesh, Mohsen Abdolmaleki, Kamal Abdolmohammadi, Hamideh Aghaei, Fatemeh Dadgar Pakdel, Yousef Fatahi, Narjes Soleimanifar, Mahdi Zavvar & Mohammad Hossein Nicknam. (2018) Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomedicine & Pharmacotherapy 100, pages 198-204.
Crossref
Daniel Wendling. (2015) La spondyloarthrite : vers une prise en charge personnalisée ?. Revue du Rhumatisme Monographies 82:1, pages 1-2.
Crossref
Daniel Wendling, Cédric Lukas, Julien Paccou, Pascal Claudepierre, Laurence Carton, Bernard Combe, Philippe Goupille, Francis Guillemin, Christophe Hudry, Corinne Miceli-Richard & Maxime Dougados. (2014) Recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite. Revue du Rhumatisme 81:1, pages 6-15.
Crossref
Daniel Wendling, Cédric Lukas, Julien Paccou, Pascal Claudepierre, Laurence Carton, Bernard Combe, Philippe Goupille, Francis Guillemin, Christophe Hudry, Corinne Miceli-Richard & Maxime Dougados. (2014) Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis. Joint Bone Spine 81:1, pages 6-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.